Relugolix Plus Radiotherapy in Localized or Advanced Prostate Cancer
This study examines 2 randomized clinical trials to assess the efficacy and safety of the oral gonadotropin-releasing hormone antagonist relugolix with radiotherapy for treating prostate cancer.